A systems biology approach for the identification of significantly perturbed genes

Identifying the genes involved in the mechanisms differentiating two phenotypes is a crucial step in the analysis of high-throughput gene expression experiments. Although in the last decade several approaches have been developed in order to address this challenge, a number of important issues remain open. Even the most widely used approaches fail to incorporate information about known interactions among genes, and they often fail to yield reproducible results across similar experiments, both in terms of the set of genes and in terms of the mechanisms related to those genes. Here we propose a novel systems biology approach able to i) identify the genes that are involved in a biological mechanism relevant to the condition in analysis and ii) yield reproducible results across multiple data sets related to the same condition. This is achieved by using gene expression levels and existing knowledge about the interactions among genes. We apply our method on four data sets describing two conditions, and we compare our results with the results of the classical approach of identifying genes based on their differential expression and p-values. The results show that our approach is better at identifying genes that are involved in the mechanisms relevant to the phenotype in analysis, as well as producing more consistent results across data sets describing the same biological condition.

[1]  Mario Lauria,et al.  Strengths and limitations of microarray-based phenotype prediction: lessons learned from the IMPROVER Diagnostic Signature Challenge , 2013, Bioinform..

[2]  Sorin Draghici,et al.  Incorporating Gene Significance in the Impact Analysis of Signaling Pathways , 2012, 2012 11th International Conference on Machine Learning and Applications.

[3]  Robert Gentleman,et al.  Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer , 2012, Nature Genetics.

[4]  Z. Werb,et al.  The extracellular matrix: A dynamic niche in cancer progression , 2012, The Journal of cell biology.

[5]  Christina Backes,et al.  An integer linear programming approach for finding deregulated subgraphs in regulatory networks , 2011, Nucleic acids research.

[6]  A. Papavassiliou,et al.  FAK, CD44v6, c-Met and EGFR in colorectal cancer parameters: tumour progression, metastasis, patient survival and receptor crosstalk , 2012, International Journal of Colorectal Disease.

[7]  Bin Zhao,et al.  The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal , 2011, Nature Cell Biology.

[8]  Martin Ester,et al.  Optimally discriminative subnetwork markers predict response to chemotherapy , 2011, Bioinform..

[9]  Hui-Young Lee,et al.  Fyn mediates transforming growth factor-beta1-induced down-regulation of E-cadherin in human A549 lung cancer cells. , 2011, Biochemical and biophysical research communications.

[10]  Hong Chen,et al.  Differential expression and function of the caveolin-1 gene in non-small cell lung carcinoma. , 2011, Oncology reports.

[11]  M. Sughrue,et al.  Cancer and the Complement Cascade , 2010, Molecular Cancer Research.

[12]  Eli Upfal,et al.  Algorithms for Detecting Significantly Mutated Pathways in Cancer , 2010, RECOMB.

[13]  W. V. van IJcken,et al.  Gene Expression-Based Classification of Non-Small Cell Lung Carcinomas and Survival Prediction , 2010, PloS one.

[14]  I. Kim,et al.  PTEN/pAkt/p53 signaling pathway correlates with the radioresponse of non-small cell lung cancer. , 2010, International journal of molecular medicine.

[15]  Z. Qian,et al.  High expression of Toll-like receptor 4/myeloid differentiation factor 88 signals correlates with poor prognosis in colorectal cancer , 2010, British Journal of Cancer.

[16]  H. Tian,et al.  Depletion of PI3K p85α induces cell cycle arrest and apoptosis in colorectal cancer cells , 2009 .

[17]  H. Tian,et al.  Depletion of PI3K p85alpha induces cell cycle arrest and apoptosis in colorectal cancer cells. , 2009, Oncology reports.

[18]  Marc Ladanyi,et al.  WNT/TCF Signaling through LEF1 and HOXB9 Mediates Lung Adenocarcinoma Metastasis , 2009, Cell.

[19]  Wei-peng Zhao,et al.  Neutralization of complement regulatory proteins CD55 and CD59 augments therapeutic effect of herceptin against lung carcinoma cells. , 2009, Oncology reports.

[20]  Francesca Molinari,et al.  PIK3CA mutations in colorectal cancer are associated with clinical resistance to EGFR-targeted monoclonal antibodies. , 2009, Cancer research.

[21]  Holger Sültmann,et al.  Global gene expression analysis reveals specific patterns of cell junctions in non-small cell lung cancer subtypes. , 2009, Lung cancer.

[22]  Zsolt Tulassay,et al.  Inflammation, Adenoma and Cancer: Objective Classification of Colon Biopsy Specimens with Gene Expression Signature , 2008, Disease markers.

[23]  Richard M. Karp,et al.  Detecting Disease-Specific Dysregulated Pathways Via Analysis of Clinical Expression Profiles , 2008, RECOMB.

[24]  Ying-Xuan Chen,et al.  Inhibition of JAK1, 2/STAT3 signaling induces apoptosis, cell cycle arrest, and reduces tumor cell invasion in colorectal cancer cells. , 2008, Neoplasia.

[25]  Yoshihiro Yamanishi,et al.  KEGG for linking genomes to life and the environment , 2007, Nucleic Acids Res..

[26]  J. Minna,et al.  Oncogenic activation of c-Abl in non-small cell lung cancer cells lacking FUS1 expression: inhibition of c-Abl by the tumor suppressor gene product Fus1 , 2007, Oncogene.

[27]  P. Khatri,et al.  A systems biology approach for pathway level analysis. , 2007, Genome research.

[28]  Y. Takano,et al.  Phosphorylated GSK3beta-ser9 and EGFR are good prognostic factors for lung carcinomas. , 2007, Anticancer research.

[29]  C. Der,et al.  Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer , 2007, Oncogene.

[30]  A. Darzi,et al.  Chemokine expression is associated with the accumulation of tumour associated macrophages (TAMs) and progression in human colorectal cancer , 2007, Clinical & Experimental Metastasis.

[31]  Serban Nacu,et al.  Gene expression network analysis and applications to immunology , 2007, Bioinform..

[32]  K. Ho,et al.  A Susceptibility Gene Set for Early Onset Colorectal Cancer That Integrates Diverse Signaling Pathways: Implication for Tumorigenesis , 2007, Clinical Cancer Research.

[33]  M. Kenward,et al.  An Introduction to the Bootstrap , 2007 .

[34]  D. Lin,et al.  Abnormal β-Catenin and Reduced Axin Expression Are Associated With Poor Differentiation and Progression in Non–Small Cell Lung Cancer , 2006 .

[35]  Hyun-Ah Kim,et al.  Expression of caveolin-1 is correlated with Akt-1 in colorectal cancer tissues. , 2006, Experimental and molecular pathology.

[36]  S. Brand,et al.  Cell differentiation dependent expressed CCR6 mediates ERK‐1/2, SAPK/JNK, and Akt signaling resulting in proliferation and migration of colorectal cancer cells , 2006, Journal of cellular biochemistry.

[37]  Z. Szallasi,et al.  Reliability and reproducibility issues in DNA microarray measurements. , 2006, Trends in genetics : TIG.

[38]  Yiling Lu,et al.  Exploiting the PI3K/AKT Pathway for Cancer Drug Discovery , 2005, Nature Reviews Drug Discovery.

[39]  S. Brand,et al.  CXCR4 and CXCL12 are inversely expressed in colorectal cancer cells and modulate cancer cell migration, invasion and MMP-9 activation. , 2005, Experimental cell research.

[40]  Neil O. Carragher,et al.  The role of focal-adhesion kinase in cancer — a new therapeutic opportunity , 2005, Nature Reviews Cancer.

[41]  C. Forst,et al.  Differential network expression during drug and stress response , 2005, Bioinform..

[42]  Sunil Singhal,et al.  Prognostic Implications of Cell Cycle, Apoptosis, and Angiogenesis Biomarkers in Non–Small Cell Lung Cancer: A Review , 2005, Clinical Cancer Research.

[43]  Pankaj Agarwal,et al.  Inferring pathways from gene lists using a literature-derived network of biological relationships , 2005, Bioinform..

[44]  U. Lindforss,et al.  Persistence of K-ras mutations in plasma after colorectal tumor resection. , 2005, Anticancer research.

[45]  Gordon K Smyth,et al.  Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray Experiments , 2004, Statistical applications in genetics and molecular biology.

[46]  V. Keshamouni,et al.  Peroxisome proliferator-activated receptor-γ activation inhibits tumor progression in non-small-cell lung cancer , 2004, Oncogene.

[47]  K. Fransén,et al.  Mutation analysis of the BRAF, ARAF and RAF-1 genes in human colorectal adenocarcinomas. , 2003, Carcinogenesis.

[48]  Adam J. Smith,et al.  The Database of Interacting Proteins: 2004 update , 2004, Nucleic Acids Res..

[49]  Biao He,et al.  Activation of the Wnt pathway in non small cell lung cancer: evidence of dishevelled overexpression , 2003, Oncogene.

[50]  Jeffrey S. Morris,et al.  The 15-lipoxygenase-1 product 13-S-hydroxyoctadecadienoic acid down-regulates PPAR-δ to induce apoptosis in colorectal cancer cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[51]  Rafael A Irizarry,et al.  Exploration, normalization, and summaries of high density oligonucleotide array probe level data. , 2003, Biostatistics.

[52]  A. Kakkar,et al.  Platelets and cancer. , 2002, The Lancet. Oncology.

[53]  Benno Schwikowski,et al.  Discovering regulatory and signalling circuits in molecular interaction networks , 2002, ISMB.

[54]  J. Tartaglia,et al.  Therapeutic vaccines against melanoma and colorectal cancer. , 2001, Vaccine.

[55]  K. Sugimachi,et al.  Expression of E-cadherin and β-catenin in human non-small cell lung cancer and the clinical significance , 2000 .

[56]  M. Ashburner,et al.  Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.

[57]  R. Tibshirani,et al.  An Introduction to the Bootstrap , 1995 .

[58]  E. Brambilla,et al.  Basal cell (basaloid) carcinoma of the lung: a new morphologic and phenotypic entity with separate prognostic significance. , 1992, Human pathology.

[59]  J. Mattick,et al.  Genome research , 1990, Nature.

[60]  I. M. Neiman,et al.  [Inflammation and cancer]. , 1974, Patologicheskaia fiziologiia i eksperimental'naia terapiia.